PJ Kelleher | LifeSci Advisors |
John Tucker | Chief Executive Officer |
Steve Parsons | Senior Vice President of Commercial |
Rachael Nokes | Chief Financial Officer |
John Mohr | Senior Vice President, Clinical Development and Medical Affairs |
Glen Santangelo | Jefferies |
Roanna Ruiz | SVB Securities |
Stacy Ku | TD Cowen |
Douglas Tsao | H.C. Wainwright |
Nazibur Rahman | Maxim Group |
Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, PJ Kelleher from LifeSci Advisors.